Menu

Downloads

  • Dixon PH, Sambrotta M, Chambers J, Taylor-Harris P, Syngelaki A, Nicolaides K, Knisely AS, Thompson RJ, Williamson, C. An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy. Sci Rep 2017; 7: 11823; DOI:10.1038/s41598-017-11626-x.
    PDF
  • Pataia V, Dixon, PH, Williamson C. Pregnancy and bile acid disorders. American Journal of Physiology – Gastrointestinal and Liver Physiology 2017; 313(1): G1–G6. doi: 10.1152/ajpgi.00028.2017
    http://ajpgi.physiology.org/content/313/1/G1
    PDF
  • Schultz F, Hasan A, Alvarez-Laviada A, Miragoli, M, Bhogal N, Wells S, Poulet C, Chambers, J, Williamson C, Gorelik J. The protective effect of ursodeoxycholic acid in an in vitro model of the human fetal heart occurs via targeting cardiac fibroblasts. Progr Biophys Molec Biol 2016; http://dx.doi.org/10.1016/j.pbiomolbio.2016.01.003
    PDF
  • Abu-Hayyeh S, Ovadia C, Lieu T, Jensen DD, Chambers J, Dixon PH, Lovgren-Sandblom A, Bolier R, Tolenaars D, Kremer AE, Syngelaki A, Noori M, Williams D, Marin JJG, Monte MJ, Nicolaides KH, Beuers U, Oude-Elferink R, Seed PT, Chappell L, Marschall H-U, Bunnett NW, Williamson C Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum. Hepatology 2015; doi: 10.1002/hep.28265
    PDF
  • Geenes V, Chambers J, Khurana R, Wikström Shemer E, Sia W, Mandair D, Elias E, Marschall H-U, Hague W, Williamson C (2015) Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology, Volume 189. pages 59–63
    PDF
  • Geenes V, Chappell LC, Seed PT, Steer PJ, Knight, M, Williamson C Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. Hepatology 2014; First published online 26 February 2014; DOI: 10.1002/hep.26617
    PDF
  • Chappell LC, Gurung V, Seed PT, Chambers J, Williamson C, Thornton JG. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. BMJ 2012; 344 doi: 10.1136/bmj.e3799
    HTML
  • Geenes V, Williamson C (2009) Intrahepatic cholestasis of pregnancy. World Journal of Gastroenterology, Volume 15, Issue 17, Pages 2049–2066.
    This is the most recent review of our current state of knowledge of ICP.
    HTML
    PDF
  • Glantz A, Marschall H-U, Mattsson L-Å (2004) Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology, Volume 40, Issue 2, Pages 467–474. (DoI: 10.1002/hep.20336)
    This paper reports more extensively the connection between high levels of bile acids and potential risk to the baby.
    HTML
    PDF
  • Kremer AE et al. (2010) Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology, Volume 139, Pages 1008–1018.
    PDF
  • Wikström Shemer E et al. (2013) Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study. British Journal of Obstetrics and Gynaecology, DOI: 10.1111/1471-0528.12174.
    PDF